Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: Relationship to thrombocytopenia with megakaryocytic hypoplasia

Arthritis and Rheumatism

Volumn 46, Issue 8, 2002, Pages 2148-2159

  Kuwana, Masataka ^a   Okazaki, Yuka ^a   Kajihara, Mikio ^a   Kaburaki, Junichi ^b   Miyazaki, Hiroshi ^c   Kawakami, Yutaka ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO ELECTRIC POWER COMPANY   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C MPL ANTIBODY; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; PROTEIN C MPL; RECOMBINANT ANTIGEN; RECOMBINANT C MPL; RECOMBINANT THROMBOPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BONE MARROW HYPOPLASIA; CELL PROLIFERATION; CELL SURFACE; CLINICAL FEATURE; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOPLASIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; BONE MARROW CELLS; CELL DIVISION; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEGAKARYOCYTES; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036675111     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10420     Document Type: Article

References (38)

1. The clinical presentation of systemic lupus erythematosus
2. Prognosis in systemic lupus erythematosus: Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death
3. Hematologic and lymphoid abnormalities in systemic lupus erythematosus
4. Amegakaryocytic thrombocytopenia in systemic lupus erythematosus
5. Acquired amegakaryocytic thrombocytopenia: Report of a case and review of literature
6. Acquired amegakaryocytic thrombocytopenic purpura with humoral inhibitory factor for megakaryocytic colony formation
7. Cell mediated amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus
8. Acquired pure amegakaryocytic thrombocytopenia
9. Thrombopoietin: The primary regulator of platelet production
10. cMpl ligand is a humoral regulator of megakaryocytopoiesis
11. c-Mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
12. Systemic lupus erythematosus: Pathogenesis
13. The 1982 revised criteria for the classification of systemic lupus erythematosus
14. Autoimmune (idiopathic) thrombocytopenic purpura
15. Derivation of the SLEDAI: A disease activity index for lupus patients
16. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabelled cell extracts
17. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura
18. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: Role in production of anti-platelet autoantibody
19. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation
20. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens
21. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides
22. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin
23. Autoantibodies neutralizing thrombopoietin in a patient with amegakaryocytic thrombocytopenic purpura
24. Thrombopoietin serum levels in patients with aplastic anaemia: Correlation with platelet count and persistent elevation in remission
25. Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporin
26. An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura
27. Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura
28. T suppressor activated lymphocytes (CD8+/DR+) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpura
29. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura
30. Human platelets as a model for the binding and degradation of thrombopoietin
31. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura
32. Chronic idiopathic thrombocytopenic purpura
33. 111In-labelled autologous platelet turnover in idiopathic thrombocytopenic purpura
34. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: Evidence of both impaired platelet production and increased platelet clearance
35. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura
36. Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment
37. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: Their relationship with the observed thrombocytopenia
38. Human platelets display high-affinity receptors for thrombopoietin